Ma Huang Xi Xin Fu Zi Tang (Ephedra, Asarun, and Prepared Aconite Decoction)

Actions

Indications

Western Uses:

• What is Ma Huang Xi Xin Fu Zi Tang used for in modern practice?

  In modern practice, Ma Huang Xi Xin Fu Zi Tang (often transliterated Mahuang Fuzi Xixin decoction) is most studied for allergic rhinitis, and is also referenced traditionally for a cold or flu-like onset in someone constitutionally cold, frail, or elderly — presentations where an ordinary exterior-releasing formula alone is considered insufficient because the underlying yang is already weak.

  These are biomedical correlates of the formula's traditional pattern, not a claim that it treats any diagnosed disease; the systematic-review evidence for allergic rhinitis specifically found it was not shown to outperform conventional Western treatment. Any use for a diagnosed condition belongs with a qualified practitioner and appropriate medical care.

  Source: PubMed 29636787 (systematic review, allergic rhinitis); traditional-use correlates cross-referenced against multiple online sources. Reference only, not a treatment claim.

Originally Appeared In:

• On Cold Damage (Shang Han Lun)

Notes:

• How does Ma Huang Xi Xin Fu Zi Tang differ from Ma Huang Tang and Gui Zhi Jia Fu Zi Tang?

  All three formulas come from the Shang Han Lun and all use Ma Huang or a warming strategy for an exterior pattern, but they target different underlying constitutions.

  • vs Ma Huang Tang: Ma Huang Tang releases a robust Tai-Yang wind-cold excess pattern in an otherwise healthy person with no underlying yang deficiency; it contains no Fu Zi and is not built to protect a depleted Kidney yang the way this formula is.
  • vs Gui Zhi Jia Fu Zi Tang (Cinnamon Twig Decoction plus Aconite): that formula addresses continued sweating and yang depletion that has already resulted from over-sweating a Tai-Yang case; it uses Gui Zhi's gentler harmonizing release rather than Ma Huang's stronger opening action, reflecting a milder, already-more-depleted presentation rather than a fresh invasion striking a constitutionally cold person.

  Source: Shang Han Lun; cross-referenced against multiple online sources for formula-family comparisons.

Clinical Studies & Research:

• Is there modern research on Ma Huang Xi Xin Fu Zi Tang?

  Yes, primarily on allergic rhinitis, with additional preclinical work on influenza infection in a Kidney-yang-deficiency model. A systematic review of six randomized controlled trials (576 participants) found the decoction was not shown to outperform conventional Western treatment for allergic rhinitis, though evidence quality in the underlying trials was rated low to very low. More recent mechanistic studies report that the decoction reduces nasal epithelial pyroptosis (a form of inflammatory cell death) via the NLRP3/Caspase-1/GSDMD-N pathway in allergic rhinitis models. Separately, an animal study modeling Kidney-Yang deficiency alongside influenza A infection found the decoction reduced mortality, lung fluid accumulation, and pro-inflammatory cytokines (IL-6, MCP-1, TNF-α) while raising anti-inflammatory IL-10 and antioxidant activity — a laboratory angle consistent with the formula's traditional logic of treating a cold invasion together with an underlying deficiency.

  Sources: PubMed 29636787 (systematic review, allergic rhinitis, 2018); PubMed 38479543 ("Mahuang Fuzi Xixin decoction alleviates allergic rhinitis by inhibiting NLRP3/Caspase-1/GSDMD-N-mediated pyroptosis," J Ethnopharmacol, 2024); PubMed 27401293 ("Mahuang-Xixin-Fuzi decoction reduces the infection of influenza A virus in Kidney-Yang deficiency syndrome mice," J Ethnopharmacol, 2016). Research context, not a therapeutic claim.